<![CDATA[Kenvue Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=43126>Thu, 05 Mar 2026 20:43:36 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Everyday Care in Action: Thousands of Kenvue Employees Come Together Across 21 Markets to Help Advance Healthier Communities]]>https://www.newswire.co.kr/newsRead.php?no=1011359Sun, 18 May 2025 15:00:00 +0900<![CDATA[켄뷰, 21개 시장 임직원 참여로 더 건강한 지역사회 만들기 지원]]>https://www.newswire.co.kr/newsRead.php?no=1011360Sun, 18 May 2025 15:00:00 +0900<![CDATA[Kenvue Announces 5-Year Collaboration with Microsoft to Transform Digital Operations]]>https://www.newswire.co.kr/newsRead.php?no=1009579Thu, 17 Apr 2025 11:20:00 +0900<![CDATA[켄뷰, 디지털 운영 혁신 위해 마이크로소프트와 5년간의 협력 발표]]>https://www.newswire.co.kr/newsRead.php?no=1009581Thu, 17 Apr 2025 11:20:00 +0900<![CDATA[Kenvue Announces Three New Appointments to Board of Directors]]>https://www.newswire.co.kr/newsRead.php?no=1007274Tue, 11 Mar 2025 16:40:00 +0900<![CDATA[켄뷰, 이사회에 3명의 신규 임원 임명 발표]]>https://www.newswire.co.kr/newsRead.php?no=1007276Tue, 11 Mar 2025 16:40:00 +0900<![CDATA[Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists]]>https://www.newswire.co.kr/newsRead.php?no=999968Sun, 03 Nov 2024 10:45:00 +0900<![CDATA[뉴트로지나, 세계에서 가장 유명한 피부과 전문의 2인과 획기적인 협업 시작]]>https://www.newswire.co.kr/newsRead.php?no=999969Sun, 03 Nov 2024 10:45:00 +0900<![CDATA[Kenvue Drives Climate Action Strategy Forward]]>https://www.newswire.co.kr/newsRead.php?no=997299Tue, 24 Sep 2024 14:40:00 +0900<![CDATA[켄뷰, 기후 행동 전략을 추진한다]]>https://www.newswire.co.kr/newsRead.php?no=997304Tue, 24 Sep 2024 14:40:00 +0900<![CDATA[Kenvue Releases Inaugural Healthy Lives Mission Report]]>https://www.newswire.co.kr/newsRead.php?no=992278Wed, 26 Jun 2024 14:45:00 +0900<![CDATA[켄뷰, 첫 번째 ‘건강한 삶 사명’ 보고서 발표]]>https://www.newswire.co.kr/newsRead.php?no=992281Wed, 26 Jun 2024 14:45:00 +0900<![CDATA[Kenvue Declares Quarterly Cash Dividend]]>https://www.newswire.co.kr/newsRead.php?no=983285Fri, 26 Jan 2024 13:30:00 +0900<![CDATA[켄뷰, 1분기 현금 배당 결정]]>https://www.newswire.co.kr/newsRead.php?no=983286Fri, 26 Jan 2024 13:30:00 +0900<![CDATA[켄뷰, 2024년 2월 8일 2023년 4분기 및 연간 실적 발표]]>https://www.newswire.co.kr/newsRead.php?no=982225Sun, 07 Jan 2024 11:26:54 +0900<![CDATA[Kenvue to Announce Fourth Quarter and Full Year 2023 Results on February 8, 2024]]>https://www.newswire.co.kr/newsRead.php?no=982224Sun, 07 Jan 2024 11:23:00 +0900<![CDATA[Kenvue to Participate in the Morgan Stanley Global Consumer & Retail Conference on December 6, 2023]]>https://www.newswire.co.kr/newsRead.php?no=979811Wed, 29 Nov 2023 11:50:00 +0900<![CDATA[켄뷰, 2023년 12월 6일 모건스탠리 글로벌 소비자 콘퍼런스에 참가]]>https://www.newswire.co.kr/newsRead.php?no=979812Wed, 29 Nov 2023 11:50:00 +0900<![CDATA[Kenvue to Announce Third Quarter 2023 Results on October 26, 2023]]>https://www.newswire.co.kr/newsRead.php?no=975101Sun, 24 Sep 2023 11:15:00 +0900<![CDATA[켄뷰, 10월 26일 2023년 3분기 경영실적 발표 예정]]>https://www.newswire.co.kr/newsRead.php?no=975102Sun, 24 Sep 2023 11:15:00 +0900<![CDATA[Kenvue Becomes a Fully Independent Company Following Final Separation from Johnson & Johnson]]>https://www.newswire.co.kr/newsRead.php?no=972846Thu, 24 Aug 2023 09:15:00 +0900<![CDATA[켄뷰, 존슨앤드존슨에서 최종 분리 후 완전 독립 회사로 출범]]>https://www.newswire.co.kr/newsRead.php?no=972849Thu, 24 Aug 2023 09:15:00 +0900<![CDATA[Kenvue To File Form S-4 Registration Statement in Connection with Johnson & Johnson Exchange Offer Announcement]]>https://www.newswire.co.kr/newsRead.php?no=971184Tue, 25 Jul 2023 11:30:00 +0900<![CDATA[켄뷰, 존슨앤드존슨 주식 교환 제안 발표에 따라 양식 S-4 등록 신고서 제출]]>https://www.newswire.co.kr/newsRead.php?no=971185Tue, 25 Jul 2023 11:30:00 +0900<![CDATA[Kenvue Initiates Quarterly Cash Dividend]]>https://www.newswire.co.kr/newsRead.php?no=970977Fri, 21 Jul 2023 11:45:00 +0900